Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- General Proximity is a breakthrough biotech platform company that has developed the proprietary OmniTAC platform to pioneer the next generation of induced proximity medicines, targeting undruggable proteins associated with cancer, cardiometabolic disease, neurodegeneration, and longevity.
- Market
- Induced proximity medicines targeting undruggable proteins
- Location
-
San Francisco,
California,
USA
- Coinvestors
- Y Combinator, age1, Modi Ventures, Wilson Sonsini, Jeff Dean, Uri Lopatin, Ben Mann, Alec Nielsen, Trevor Martin, Juan Benet, Nish Bhat, Jim Dahl, De Thompson V
Links